SERENA-2: Camizestrant vs Fulvestrant in Advanced ER+/HER2- Breast Cancer
Medical oncologists discuss oral SERDs, with a focus on the SERENA-2 trial looking at camizestrant in patients with advanced ER+/HER2- breast cancer.
Source: onclive.com
Serena 2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Serena 2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Serena 2 Today - Breaking & Trending Today